Yarrow Bioscience, Inc.
YARW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566044
No open-market purchases or sales by Yarrow Bioscience, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding YARW, Q2 2026
No superinvestor reported holding YARW at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Yarrow Bioscience, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2025 (view filing) | Jan 15 | 1 day | Lepore Patrick GDirector | PPurchase | +15.0K | $2.92 | +$43.8K | +41.1%51.5K after | |
| Nov 17, 2023 (view filing) | Nov 15 | 2 days | Lepore Patrick GDirector | PPurchase | +13.0K | $3.91 | +$50.8K | +55.4%36.5K after | |
| Mar 22, 2023 (view filing) | Mar 20 | 2 days | Lepore Patrick GDirector | PPurchase | +20.0K | $2.48 | +$49.6K | +576.0%23.5K after | |
| Mar 22, 2023 (view filing) | Mar 20 | 2 days | Harsch MutyaChief Legal Officer and GC | PPurchase | +10.0K | $2.50 | +$25.0K | +78.6%22.7K after | |
| Dec 2, 2021 (view filing) | Nov 30 | 2 days | Lepore Patrick GDirector | PPurchase | +12.5K | $1.02 | +$12.8K | +25.0%62.5K after | |
| Aug 26, 2021 (view filing) | Aug 25 | 1 day | Lepore Patrick GDirector | PPurchase | +12.5K | $1.60 | +$20.0K | +33.3%50.0K after | |
| Aug 18, 2021 (view filing)7:19 PM ET | Aug 16 | 2 days | Edelman Joseph and 2 others10% Owner | SSale | −250.0K | $1.74 | −$435.0K | −4.8%4.94M after | |
| Aug 17, 2021 (view filing)4:46 PM ET | Aug 13 | 4 days | Edelman Joseph and 2 others10% Owner | SSale | −250.0K | $1.84 | −$460.0K | −4.6%5.19M after | |
| Aug 16, 2021 (view filing)6:24 PM ET | Aug 12 | 4 days | Edelman Joseph and 2 others10% Owner | SSale | −338.9K | $2.23 | −$755.7K | −5.9%5.44M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Yarrow Bioscience, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding YARW in 13F filings for Q2 2026.